Pharmstar Pharmaceuticals, Inc.

The Makers of Aquaprin

Page 1 of 2

Home Why Aquaprin? Investor Info Contact Us Detailed Product Info Supporting Articles

Pharmstar Pharmaceuticals, Inc. (PHAR) is a publicly traded company. Pharmstar has completed all patenting of AQUAPRIN and the necessary protection of its intellectual property. All research and development of AQUAPRIN has been completed, and the company is preparing a full scale production facility at its headquarters in Wilson, NC, for retail marketing. Listen to Bill Chappas interview with CEO and Chairman Howard Phykitt Bill Chappas Interview Howard Phykitt Mr. Phykitt has extensive experience in the design and implementation of pharmaceutical manufacturing products. your email

Investor Information
919 794 7000, Press Extension 5

Request Information
To request more information about Aquaprin, please complete the form below. your name

enter request details here

Working with companies such as Monsanto, Warner-Lambert, Durkee Submit Foods, Johnson & Johnson (McNeil), American Home Products and many other pharmaceutical companies, Mr. Phykitt has been tabbed with the bringing a litany of current name brand products to full production. He began his career with Teledyne Isotopes, developing systems for the detection of radioactivity in the late 50s. He moved into the pharmaceutical manufacturing industry in 1975, developing granulation and coating technology that is used today by companies such as Eli Lily and Glaxo Smithkline in the production of pharmaceutical products. In 1984, Mr. Phykitt founded Granutec, Inc. where he developed fluid bed micro-encapsulation for use in the pharmaceutical and agriculture industries. By 1988, Granutec grew to $6 million in sales, and from there to over $40 million in sales by 1990. In 1993, the company had grown to over $60 million in sales to companies such as Walmart, Eckerd, Perry Drug, and Rite Aid. By 1993, Mr. Phykitt began the research and development of a safer, more effective delivery of aspirin products. By 1997, he had received 3 patents in this developing, and through various vehicles and personal investment, began perfecting the development of Aquaprin. After over 17 years of researching, testing, patenting and developing Aquaprin, he is now ready to bring his most important work to the $30 billion pain management industry. Mr. Phykitt is a member of the American Management Association with fluency in FDA regulatory affairs, quality control and manufacturing. Mr. Phykitt attended Columbia University.

http://www.pharmstarinc.com/investor-info.html

4/29/2013

Pharmstar Pharmaceuticals, Inc. The Makers of Aquaprin

Page 2 of 2

Last Change % Change Time Bid Bid Size Ask Ask Size Day Low Day High Open Prev Close Volume 10D Ave Vol

Delayed Pharmstar Pharmaceuticals Inc (PHAR) 0.002 Intraday 5 Dy 1 Mo 3 Mo 6 Mo 1 Yr 2 Yr 5 Yr 0.0012 37.50% 15:29:48 0.00 0 0.00 0 0.002 0.0025 0.0022 0.0032 598,300 1,797,086

Hide Volume

PharmStar Pharmaceuticals, Inc. |3914 Airport Drive Wilson, NC 27896 Telephone: 919 794 7000 | Fax: 919 794 7003 | e-mail: info@pharmstarinc.com | Sitemap

http://www.pharmstarinc.com/investor-info.html

4/29/2013